Glycopyrrolate Injection
Product Images NDC 70756-631

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70756-631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate Structural Formula (C4ea033f 136d 4ac8 A88a F59e31261ebd 01)

Chemical structure of glycopyrrolate, showing its molecular arrangement including cyclopentyl, phenyl, and quaternary ammonium components with a bromide counterion.*

FDA Label Image

1mlvial (C4ea033f 136d 4ac8 A88a F59e31261ebd 02)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, an injectable solution containing benzyl alcohol. The product is supplied as a 1 mL single-dose vial for intramuscular or intravenous use. Manufactured by Lifestar Pharma LLC, the label includes lot and expiration date fields and states the product is made in India.*

FDA Label Image

1mlcarton (C4ea033f 136d 4ac8 A88a F59e31261ebd 03)

Carton label for Glycopyrrolate Injection, USP 0.2 mg/mL by Lifestar Pharma LLC. The label indicates the product is for intramuscular or intravenous administration, contains benzyl alcohol as a preservative, and is not for use in newborns. The packaging includes storage instructions and manufacturing details.*

FDA Label Image

2mlvial (C4ea033f 136d 4ac8 A88a F59e31261ebd 04)

Label for Glycopyrrolate Injection, USP, with a strength of 0.4 mg/2 mL (0.2 mg/mL) in a 2 mL single-dose vial. The label states it contains benzyl alcohol and is for intramuscular or intravenous use. Manufactured for Lifestar Pharma LLC, made in India. Includes areas for lot number and expiration date.*

FDA Label Image

2mlcarton (C4ea033f 136d 4ac8 A88a F59e31261ebd 05)

Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) in single-dose vials. Label shows the product name, strength, dosage form, route for intramuscular or intravenous administration, contains benzyl alcohol, and is not for use in newborns. Manufactured for Lifestar Pharma LLC with storage instructions at controlled room temperature.*

FDA Label Image

5mlvial (C4ea033f 136d 4ac8 A88a F59e31261ebd 06)

Label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) in a 5 mL multiple dose vial by Lifestar Pharma LLC. The injection is for intramuscular or intravenous use and contains benzyl alcohol as a preservative. The label includes storage instructions and notes it is not for use in newborns.*

FDA Label Image

5mlcarton (C4ea033f 136d 4ac8 A88a F59e31261ebd 07)

Carton label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) by Lifestar Pharma LLC. The label indicates it is for intramuscular or intravenous administration, contains benzyl alcohol preservative, and is not for use in newborns. The package includes 25 vials of 5 mL each. Storage instructions and manufacturer information are also shown.*

FDA Label Image

20mlvial (C4ea033f 136d 4ac8 A88a F59e31261ebd 08)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) in a 20 mL multiple dose vial. Indicated for intramuscular or intravenous administration. Contains benzyl alcohol preservative. Manufactured by Lifestar Pharma LLC, Made in India. Includes storage instructions and barcode.*

FDA Label Image

20mlcarton (C4ea033f 136d 4ac8 A88a F59e31261ebd 09)

Packaging label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) by Lifestar Pharma LLC. The label states it is for intramuscular or intravenous administration, includes 10 multiple dose vials of 20 mL each, and indicates it contains benzyl alcohol and is not for use in newborns. Storage instructions and manufacturing details are also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.